






New neurons are generated in the mammalian brain 
throughout adult life. Slowly dividing and self-renewing 
neural stem cells (NSCs) are present in the subvent-
ricular zone (SVZ) of the lateral ventricles and in the 
subgranular zone (SGZ) of the hippocampal dentate 
gyrus. NSCs generate rapidly proliferating neural 
progenitor cells that ultimately differentiate to produce 
thousands of new neurons each day in adult rats [1]. 
The progeny of SVZ NSCs migrate to the olfactory bulb 
where they mature into inhibitory interneurons with 
roles in olfactory learning and memory [2]. SGZ NSCs 
produce excitatory neurons that integrate into the 
dentate gyrus and are critical for certain types of 
hippocampus-dependent learning and memory [1,3]. 
Neurogenesis declines with age [4-6] and is impaired by 
various types of stress [7] and brain inflammation [8]. 
Exercise and environmental enrichment increase 
neurogenesis, and can reverse the effects of aging [9,10]  
 
 

































and stress [11]. Excessive NSC proliferation, however, 
can promote functional exhaustion of these cells [12-14] 
and in some cases can lead to glioma, a form of brain 
cancer [15-17]. Thus, regulation of NSC proliferation 
and differentiation is pivotal for adult brain homeostasis 
and is disrupted during aging. 
 
Intrinsic and extrinsic factors regulate NSC function 
largely by directing changes in gene expression. A 
number of transcription factors and chromatin modifiers 
control gene expression in adult NSCs, thereby 
affecting NSC number and ability to differentiate into 
multiple cell types. These regulators include the 
polycomb member Bmi1 [18-20], the transcriptional 
repressor Tlx [21,22], and the FoxO family of 
transcription factors [13,14]. MicroRNAs (miRNAs) 
represent an additional layer of gene expression control 
and have recently emerged as key regulators of 
embryonic and adult stem cells [23,24]. miRNAs are 
single-stranded ~23-nucleotide RNA molecules that are 
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signaling.  These  results  suggest  that  miR‐106b~25  regulates  NSPC  function  and  is  part  of  a  network  involving  the
insulin/IGF‐FoxO pathway, which may have important implications for the homeostasis of the NSC pool during aging. 
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In the cytoplasm, miRNAs direct destabilization and 
translational repression of target mRNAs by binding 
sites usually in mRNA 3’ untranslated regions. This 
miRNA-directed downregulation of gene expression 
generally requires a complementary match between the 
mRNA target site and the second to seventh nucleotides 
of the miRNA 5’ end (the “seed sequence”). It also 
depends on other regions of complementary pairing 
between the mRNA site and the miRNA, the presence 
of other miRNA-targeted sites, and the mRNA structure 
at this region [26]. Several hundred miRNAs have been 
identified in humans and mice [27]. As each miRNA 
potentially targets hundreds of different mRNAs [28], 
miRNAs can coordinate cell behaviors by fine-tuning 
gene expression [26,29]. 
 
A number of miRNAs recently have been found to 
regulate adult NSCs in vivo and in culture [30]. For 
example, two miRNAs, let-7b and miR-9, inhibit NSC 
proliferation and promote neuronal differentiation by 
suppressing Tlx and the oncogenic chromatin regulator 
Hmga2 [31-33]. In addition, miR-124 promotes 
differentiation of SVZ NSCs into neuroblasts by 
repressing the expression of the transcription factor 
Sox9 [34]. Finally, miR-184 and miR-137 trigger NSC 
proliferation and inhibit differentiation by repressing the 
NSC fate-regulator Numblike [35] and the polycomb 
methyltransferase Ezh2 [36], respectively. Thus, miR-
124, miR-9, and let-7b elicit NSC differentiation, while 
miR-184 and miR-137 increase proliferation at the 
expense of differentiation potential. miRNAs that 
promote the expansion of NSCs while maintaining their 
ability to differentiate have not yet been identified. 
 
The miRNAs in the miR-17 family are attractive 
candidates for this function. Specific miR-17 family 
members are overexpressed in a variety of cancers, 
including glioma and glioblastoma brain cancers [37-
41], and promote cancer cell proliferation and survival 
[42-45]. Furthermore, in embryonic stem cells, miR-17 
family members are repressed by the REST neuronal 
gene silencer [46], which negatively regulates neuro-
genesis [47]. miR-17 member expression in the brain 
declines between late embryonic and postnatal life [48], 
which correlates with the decline in neurogenesis that 
occurs during this period [49,50]. These results suggest 
that miR-17 members may be involved in promoting 
both proliferation and neurogenesis.  
 
The miR-17 family consists of three paralogous 
polycistronic clusters on different chromosomes: miR-
17~92 (miR-17, miR-18a, miR-19a, miR-20a, miR-19b-
1, and miR-92a-1), miR-106b~25 (miR-106b, miR-93, 
and miR-25), and miR-106a~363 (miR-106a, miR-18b, 
miR-20b, miR-19b-2, miR-92a-2, and miR-363). 
Members of each cluster belong to one of four groups 
with similar seed sequences and therefore similar 
mRNA targets [51]. Within the miR-17 family, 
members of the miR-106b~25 cluster (miR-106b, miR-
93, and miR-25) appear to be the most strongly 
expressed in the adult brain [27,52]. Further suggesting 
a link between miR-106b~25 and neurogenesis, 
expression of the host gene for miR-106b~25, Mcm7, is 
reduced in a mouse model of Down syndrome with 
diminished numbers of neural progenitor cells and 
neurogenesis [53]. 
 
Interestingly, the miR-106b~25 genomic locus contains a 
consensus binding sequence for the FoxO transcription 
factors. FoxO factors are inhibited by the insulin/insulin-
like growth factor-1 (IGF) signaling pathway [54-56] and 
have emerged as regulators of adult NSCs both in vitro 
and in vivo [13,14]. The FoxO family promotes longevity 
in a range of species [57-59] and is involved in nematode 
lifespan regulation by the miRNA lin-4 [60]. FoxO3, one 
member of the FoxO family, has recently been associated 
with extreme longevity in humans [61-65]. The presence 
of a FoxO binding sequence in the miR-106b~25 
genomic locus raises the possibility of an interaction 
between this miRNA cluster and the insulin/IGF-FoxO 
pathway in mammals.  
 
Here we use primary cultures of neural stem/progenitor 
cells (NSPCs) from adult mice to show that miR-
106b~25 promotes NSPC proliferation. Knocking down 
miR-25 decreases NSPC proliferation, and ectopically 
expressing miR-25 or the entire miR-106b~25 cluster 
increases proliferation. In NSPCs induced to differen-
tiate, overexpressing miR-106b~25 enhances different-
iation toward the neuronal lineage. We find that 
potential miR-25 target mRNAs are overrepresented in 
insulin/IGF signaling. Furthermore, we show that 
FoxO3 occupies a binding site near the promoter for 
miR-106b~25 in NSPCs, raising the possibility of a 
FoxO-miR-106b~25 feedback loop. Together, these 
results suggest that miR-106b~25 modulates adult 
NSPC proliferation and neuronal differentiation, which 





miR-106b, miR-93, and miR-25 are expressed in 
adult NSPC cultures  
 
We examined the expression levels of the miR-106b~25 
cluster members (miR-106b, miR-93, and miR-25; 
Figure 1A) in self-renewing or differentiating NSPCs 
isolated from young adult (3 month-old) mice. After the 
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renewal conditions or in differentiation conditions 
known to give rise to astrocytes, neurons, and 
oligodendrocytes [14,66]. We confirmed differentiation 
of NSPCs into these cell types by staining for markers 
of astrocytes (GFAP-positive), neurons (Tuj1-positive), 
and oligodendrocytes (O4-positive) [67] after seven 
days of differentiation (Figure 1B). We then tested the 
expression of miR-106b~25 by RT-qPCR in self-














































found that miR-106b, miR-93, and miR-25 were all 
expressed in self-renewing NSPCs. Expression of these 
miRNAs was not significantly changed by multi-lineage 
differentiation, although these miRNAs tended to be 
slightly upregulated during differentiation. In contrast, 
miR-9, a miRNA known to be induced by NSPC 
differentiation [33], was significantly upregulated in 
differentiating NSPCs. Together, these results indicate 
that miR-106b~25 is expressed in both self-renewing 
























































sample two‐tailed t‐test, *: p<0.05. miR-25 is important for adult NSPC proliferation  
 
We next tested whether miR-106b~25 is important for 
adult NSPC proliferation in self-renewal conditions. To 
inhibit miR-106b~25, we transfected NSPCs with 
locked nucleic acid (LNA)-modified oligonucleotides 
antisense to miR-106b, miR-93, or miR-25, or with a 
scrambled control LNA oligonucleotide. We assessed 
incorporation of the thymidine analog 5-ethynyl-
deoxyuridine (EdU) in NSPCs transfected with LNA 
probes antisense to each of the miRNAs in the miR-
106b~25 cluster or with control LNA probes. We found 
that miR-25 knockdown decreased EdU incorporation 
in NSPCs by 45% (p=0.005), whereas miR-106b or 
miR-93 knockdown did not significantly affect EdU 
incorporation in NSPCs (Figure 2). These results 
indicate that within the miR-106b~25 cluster, miR-25 is 























































































Ectopic expression of miR-25 promotes proliferation 
in adult NSPCs 
 
To test if miR-25 could promote proliferation in adult 
NSPCs, we ectopically expressed miR-25 in NSPCs 
using a retroviral vector containing the miR-25 
   





control  oligonucleotide.  Two  days  after  transfection, 














and  proliferation  were  analyzed.  (A)  miR‐25  expression 




µm.  (C)  Control  and  miR‐25‐overexpressing  NSPCs  were 
dissociated and incubated with EdU for 1 hour. Mean and 
SEM of the proportion of EdU+ cells for each condition, for 
experiments  on  4  independent  NSPC  cultures  (age  12 
weeks, passage 3‐6), are shown. Paired two‐tailed t‐test,  
*: p<0.05.  precursor and green fluorescent protein (GFP). We 
verified by RT-qPCR that miR-25 was overexpressed, 
on average by 8-fold, in NSPCs after miR-25 retrovirus 
infection (Figure 3A). We found that ectopic miR-25 
expression increased NSPC incorporation of EdU by 
18% compared to the GFP-only control (p=0.04; Figure 
3B,C). 
 
Expression of the entire miR-106b~25  cluster also 
promotes adult NSPC proliferation 
 
We next tested whether overexpressing the entire miR-
106b~25 cluster in adult NSPCs could further enhance 
the proliferation increase caused by miR-25 over-
expression. We generated a retroviral construct 
containing the 725-bp portion of the mouse gene 
encoding the miR-106b, miR-93, and miR-25 
precursors.  We verified by RT-qPCR that each member 
of miR-106b~25 was overexpressed in cells infected 
with miR-106b~25 retroviruses: miR-106b~25 express-
ion was increased 10- to 30-fold in NSPCs infected with 
miR-106b~25 retroviruses compared to control 
retroviruses (Figure 4A). We assessed the proportion of 
cells that incorporated EdU or bromodeoxyuridine 
(BrdU), another thymidine analog, in miR-106b~25 
expressing versus control NSPCs.  Ectopic expression 
of miR-106b~25 increased thymidine analog 
incorporation by an average of 21% (p=0.03; Figure 
4B,C), similar to miR-25 alone, supporting the idea that 
miR-25 is the main miR-106b~25 member influencing 
NSPC proliferation. Together, these results indicate that 
miR-106b~25 promotes adult NSPC proliferation, and 
this is likely due mainly to miR-25. 
 
Expression of the miR-106b~25 cluster promotes 
neuronal differentiation of adult NSPCs 
 
We examined how miR-106b~25 influences the 
generation of neurons from NSPCs during multi-lineage 
differentiation in culture. Because the short-term nature 
of LNA-mediated miRNA knockdown is not compatible 
with the duration of NSPC differentiation, we examined 
the effect of retrovirus overexpression of miR-106b~25 
on neuronal differentiation. We infected NSPCs with 
retroviruses expressing miR-106b~25 or control 
retroviruses and then differentiated these cells for seven 
days. We stained cells for Tuj1, a marker of neurons, 
and determined the proportion of Tuj1-positive cells 
(Figure 5). Although infected NSPCs formed relatively 
few neurons – probably a consequence of the toxicity of 
the infection – we found that compared to control 
infection, miR-106b~25 expression consistently 
increased the proportion of Tuj1-positive cells, on 
average from 0.3% to 0.9% (2.6-fold; p=0.005). These 
results indicate that ectopic expression of  miR-106b~25 
 
Figure 4. Expression of the entire miR‐106b~25 cluster 
also  enhances  adult  NSPC  proliferation.  NSPCs  were 
infected with an empty control retrovirus (expressing a GFP 
marker  only)  or  a  retrovirus  expressing  miR‐106b,  miR‐93, 
and  miR‐25  simultaneously  (miR‐106b~25).  NSPCs  were 
grown to full neurospheres for about 1 week after infection 






miR‐106b~25‐overexpressing  NSPCs  were  dissociated  and 
incubated with EdU or BrdU for 1 hour. Mean and SEM of the 
proportion of EdU+ or BrdU+ cells for each condition, for 6 
experiments  on  independent  NSPC  cultures  (age  12‐14 
weeks,  passage  3‐14),  are  shown.  Paired  two‐tailed  t‐test,    
*: p<0.05.  
   










































can enhance neurogenesis in culture.  
 
miR-25 has a number of predicted targets in the 
TGFβ and insulin/IGF-FoxO pathways 
 
We next sought to identify the molecular networks 
involving  miR-25,  the   main   miR-106b~25   member  
controlling NSPC proliferation. Computational 
algorithms have been developed to predict miRNA 
binding sites on target mRNA transcripts, based on 
miRNA-target site complementarity, site context, and 
site conservation [26]. To examine miR-25 targets 
through multiple bioinformatics approaches, we first  
used the TargetScan program [68] to predict the 
conserved mRNA targets of miR-25 (~600 targets) and 
then used the gene classification programs PANTHER 
[69,70] (Figure 6A) or GSEA [71] (Figure 6B) to 
associate biological processes and gene sets with these 
targets. In a parallel approach, we used the DIANA-
miRPath program [72] to predict miR-25 targets (~150) 
with the DIANA-microT-3.0-Strict algorithm [73] 
followed by comparison with the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) biological pathways 
[74] (Figure 6C). A number of interesting molecular 
networks were enriched for miR-25 targets, including 
p53 signaling, hypoxia signaling, and nitric oxide 
signaling, which are all important for NSC maintenance 
and activity [75-77]. Two signaling pathways in 
particular stood out from this target analysis: 
transforming growth factor β (TGFβ)/bone morpho-
genic protein (BMP) signaling, which was enriched for 
miR-25 targets in all three bioinformatics approaches, 
and insulin/IGF signaling, which was enriched for miR-
25 targets in the TargetScan-PANTHER analysis 
(Figure 6D). TGFβ signaling has been shown to inhibit 
adult NSC proliferation and neurogenesis [78,79], 
suggesting that miR-25 might promote NSC 
proliferation and neuronal differentiation by repressing 
TGFβ signaling. Activation of the insulin/IGF pathway, 
which inhibits FoxO factors [55], increases NSPC 
proliferation and self-renewal [80-83], and FoxO factors 
are necessary to maintain the relatively quiescent pool 
of adult NSCs [13,14]. The observation that the 
insulin/IGF-FoxO pathway is enriched for miR-25 
targets is especially pertinent because the genomic locus 
of miR-106b~25 contains a conserved FoxO binding 
sequence (Figure 7A). Furthermore, there is crosstalk 
between TGFβ signaling and the insulin/IGF-FoxO 
pathway in nematode longevity, mammalian stem cells, 
and cancer cells [84-86]. Taken together, these results 
suggest that modulation of the TGFβ and insulin/IGF 
signaling pathways may mediate part of the effects of 
miR-25 in NSPCs.  
 
The transcription factor FoxO3 binds to a site in the 
first intron of miR-106b~25/Mcm7 
 
The precursors of miR-106b~25 members are all 
located in the thirteenth intron of the protein-coding 
gene Mcm7, a member of a DNA helicase family 
required for DNA replication [87]. The first intron of 
the Mcm7 gene contains a conserved core binding 
sequence (TTGTTTAC) for the FoxO proteins [88,89] 
(Figure 7A). As the FoxO factors, particularly FoxO3, 
are important for NSC self-renewal, proliferation, and 
differentiation [13,14], we tested whether FoxO3 could 
bind to this site in the first intron of miR-
106b~25/Mcm7.    We   performed   an   electrophoretic  
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Figure  5.  miR‐106b~25  enhances  neurogenesis  in 
culture. NSPCs were infected with an empty control virus 
or  virus  to  overexpress  miR‐106b~25.  Three  days  after 
infection, NSPCs were placed in differentiation conditions 
for  7  days,  and  then  stained  for  Tuj1,  a  marker  of 
neurons. (A) Representative photos for each condition. 
Scale bar: 50 µm. (B) Mean and SEM of the proportion of 
Tuj1+  cells  (total  Tuj1+  cells/total  DAPI‐stained  nuclei) 
normalized  to  control  infection,  for  experiments  on  4 












































mobility shift assay (EMSA) in which recombinant 
FoxO3 was incubated with a 38-bp probe containing the 
FoxO binding sequence in the miR-106b~25 genomic 
locus. We found that FoxO3 caused a band shift of this 
probe, showing that FoxO3 directly binds this site in 
vitro (Figure 7B). To determine if FoxO3 is present at 
the binding site at the miR-106b~25 locus in NSPCs in 
the context of endogenous chromatin, we performed 
FoxO3 chromatin immunoprecipitation (ChIP) on 
NSPCs treated with brief growth factor removal and the 
PI3K inhibitor LY294002, to activate endogenous 












































ous FoxO3 occupies the binding site in the first intron 
of miR-106b~25/Mcm7 in cultured adult NSPCs. This 
enrichment was not present in FoxO3-null NSPCs, 
verifying the specificity of the FoxO3 ChIP. These 
results indicate that FoxO3 is bound at the genomic 
locus of the miR-106b~25 cluster. 
 
To test if FoxO3 could upregulate the transcription of 
miR-106b~25/Mcm7, we generated a luciferase reporter 
construct containing a minimal SV40 promoter and the 
500 bp surrounding the FoxO binding site in the first 
intron of miR-106b~25/Mcm7 (Figure 7A). We co-
 
Figure 6. miR‐25 targets genes involved in TGFβ and insulin/IGF signaling. (A) The PANTHER gene classification program 





Pathway  diagrams  based  on  those  in  PANTHER  Pathways  for  TGFβ  and  insulin/IGF‐Akt  signaling  pathways,  modified  for 
simplicity and with select miR‐25 predicted targets listed. 
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and with plasmids to express wild-type FoxO3, a DNA-
binding-defective inactive form of FoxO3, or 
constitutively active FoxO3. These luciferase assays 
revealed that constitutively active FoxO3 enhanced 
luciferase expression (p=0.002), and this was partly 
abrogated by mutating the FoxO binding site         
(p=0.08), indicating that FoxO3 acts as a transcriptional 
activator at this genomic locus in HEK 293T cells 
(Figure 7D).  
 
We next investigated whether FoxO3 affects 
endogenous miR-106b~25 and Mcm7 expression in 









































and Mcm7 in cultured NSPCs from wild-type versus 
FoxO3-null adult mice (Figure 7E). FoxO3-null NSPCs 
had decreased abundance of Mcm7 mRNA (p=0.01), 
indicating that Mcm7 is a target gene of FoxO3. 
However, FoxO3-null NSPCs did not display decreased 
expression of the mature forms of miR-106b, miR-93, 
and miR-25, suggesting that FoxO3 does not directly 
upregulate miR-106b~25 and might even indirectly 
repress the expression of this cluster. Together, these 
results suggest a complex regulation in which FoxO3 
activates the transcription of miR-106b~25/Mcm7, but 
may repress miR-106b~25 abundance, perhaps by a 
posttranscriptional mechanism or by acting at a separate 













































miR‐106b~25/Mcm7.  (A)  Location  of  the  FoxO  binding 
site  (FHRE)  within  the  first  intron  of  the  miR‐
106b~25/Mcm7 gene, and the sequence locations used for 
EMSA,  ChIP,  and  luciferase  experiments.  (B)  EMSA  with 
recombinant FoxO3‐GST and a radioactively‐labeled (hot) 
probe  corresponding  to  the  FoxO  binding  site  in  miR‐
106b~25/Mcm7 (FHRE WT). + Ctrl: FoxO3‐GST incubated 
with a probe for a known FoxO binding site. The specificity 








site  (‐  Ctrl).  Shown  is  the  relative  enrichment  for  1 
experiment (age 12 weeks, passage 10). These results were 
confirmed in ChIP‐Seq studies (Webb et al. submitted). (D) 
HEK  293T  cells  were  co‐transfected  with  a  plasmid  to 




Renilla  luciferase  reporter  to  normalize  for  transfection 
efficiency.  As  a  positive  control,  a  luciferase  reporter 
containing a known FoxO3‐activated site was used (+ Ctrl); 
as  a  negative  control,  a  luciferase  reporter  without  an 
enhancer  site  was  used  (‐  Ctrl).  Luciferase  activity  was 
assessed two days after transfection. Mean and SEM for 4 
independent experiments (‐ Ctrl, + Ctrl, and FHRE WT) or 2 
independent  experiments  (FHRE  Mut)  are  shown. 
Unpaired  two‐tailed  t‐test,  **:  p<0.01.  (E)  NSPCs  from 
wild‐type and FoxO3‐null mice were isolated and cultured. 
Total  RNA  was  collected,  and  the  levels  of mature miR‐
106b~25 members (relative to 5S RNA) and Mcm7 mRNA 
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miR-106b~25 members are known to promote cancer 
cell proliferation and survival [42,44], modulate 
embryonic stem cell differentiation [90], and promote 
reprogramming of mouse embryonic fibroblasts into 
induced pluripotent stem cells [91] – but the importance 
of miR-106b~25 has not been investigated in an adult 
stem cell population before. This study examined the 
role of miR-106b~25 in adult NSPCs. We found that 
miR-25 knockdown decreases NSPC proliferation, miR-
25 or miR-106b~25 overexpression increases adult 
NSPC proliferation, and miR-106b~25 overexpression 
promotes neuronal differentiation. Furthermore, FoxO3 
binds near the promoter for the host gene of miR-
106b~25 and thus has the potential to influence miR-
106b~25 expression. These results add to our 
understanding of the factors regulating NSPC activity 
and suggest that oncogenic miRNAs could have 
physiological functions in adult stem cells. 
 
miR-106b~25 and NSPC proliferation 
 
The effects of miR-106b~25 on adult NSPC 
proliferation are modest: miR-106b~25 or miR-25 
overexpression increased NSPC proliferation by about 
1.2-fold, miR-25 knockdown reduced proliferation by 
about 1.4-fold, and individual miR-106b and miR-93 
knockdowns did not affect NSPC proliferation. While 
these proliferation changes are somewhat smaller than 
those seen by miR-106b~25 manipulation in carcinoma 
cells (up to 1.8-fold in similar assays) [42,44], a modest 
effect of miR-106b~25 on NSPC proliferation could 
still be important physiologically. While an enforced 
large increase in NSC proliferation rate could result in 
tumor initiation [15,17], a weaker increase in 
proliferation rate could lead to premature stem cell 
exhaustion [12,13]. On the other hand, fewer divisions 
could reduce NSC number and neurogenesis [32,92]. 
Therefore, it is possible that miR-106b~25 overex-
pression or underexpression, both of which alter NSPC 
proliferation in culture, could affect long-term NSC 
function in vivo.  
 
Redundancy within the miR-17 family could dampen 
the influence of miR-106b~25 on NSPC proliferation in 
vitro. Knockdown of miR-106b or miR-93, which share 
the same mRNA-targeting seed sequence, did not affect 
proliferation, while knockdown of miR-25, which has a 
different seed sequence, reduced proliferation. miR-
106b and miR-93 might be able to compensate for each 
other in NSPCs, which could be tested by inhibiting 
both miRNAs simultaneously. Furthermore, it is 
possible that NSPCs buffer miR-106b~25 alteration by 
expressing miR-17 family members from the other 
paralogous clusters, thereby lessening the relative 
importance of one or even three miRNAs within this 
family, or allowing NSPCs to react to changes in miR-
106b~25 expression with compensatory changes in 
miR-17~92 or miR-106a~363 expression. Our findings 
suggest the idea that compared to cancer cells, stem 
cells may be more resilient against oncogene 
perturbation, and therefore more tolerant of certain 
gene-specific anti-cancer therapies. This may be 
particularly true for miRNAs, which have been 
duplicated during animal evolution and tend to have 
overlapping targets and functions. Such redundancy 
may have evolved not only so that duplicated miRNAs 
can be controlled by distinct cis regulatory elements, 
but perhaps also so that stem cells can absorb 
fluctuations in gene expression. 
 
miR-106b~25 in neuronal differentiation 
 
We found that miR-106b~25 promotes both NSPC 
proliferation in self-renewal conditions and neuron 
production in differentiation conditions, whereas other 
miRNAs previously studied in adult NSCs seem to 
promote one function while inhibiting the other. The 
mechanism of this effect is still unknown: miR-106b~25 
could affect NSPC tendency to produce neurons instead 
of glia, neuronal progenitor proliferation and survival, 
and neuron survival. Thus, it remains to be determined 
whether miR-106b~25 influences neurogenesis by 
directing cell fate or by regulating cell division and 
survival in specific cell types. 
 
Adult NSCs decline in number and proliferation, 
neurogenesis, and self-renewal abilities during aging 
[5]. Activities that restore NSC activity, such as 
exercise or environmental enrichment, also restore 
cognitive performance in aged mice [93,94]. As NSC 
decline may contribute to cognitive aging, investigating 
how miR-106b~25 affects neurogenesis will improve 
our understanding of the molecular mechanisms 
involved in cognitive aging. While miR-106b~25 
knockout mice have no apparent phenotype [52], 
neurogenesis and learning have not been examined in 
these mice. It would be worthwhile to investigate how 
NSCs lacking or overexpressing miR-106b~25 in vivo 
preserve their numbers and sustain neurogenesis 
throughout life. 
 
Potential signaling pathways regulated by miR-25 
 
Deciphering how stem cells sense and respond to tissue 
integrity and nutrient supply is key to understanding 
how stem cells maintain tissue homeostasis and how 
this function changes with age [83,95,96]. Analyzing 
candidate targets of miR-25 revealed that miR-25 might 
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points in each pathway. As TGFβ signaling negatively 
regulates adult NSC proliferation and neurogenesis 
[78,79], one way miR-106b~25 might promote these 
behaviors is by repressing TGFβ signaling in NSPCs. 
TGFβ Receptor-2 is directly repressed by miR-106b in 
neuroblastoma cells [97] and by miR-106b and miR-93 
in mouse embryonic fibroblasts [91]; thus, one enticing 
possibility is that TGFβ Receptor-2 is targeted by all 
miR-106b~25 members in NSPCs. While inhibitory 
Smads (Smad6 and Smad7) are also predicted miR-25 
targets, Smad7-deficient mice have increased adult 
NSPC proliferation and numbers, which may be due to 
TGFβ-independent mechanisms [98]. The net functional 
effect of miR-25 regulation of TGFβ signaling in 
NSPCs will depend on the relative expression, degree of 
miR-25 repression, and network connections of each 
member of the TGFβ pathway in NSPCs.  
 
Activation of the insulin/IGF pathway is sufficient to 
increase NSPC proliferation and self-renewal [80-83], 
while FoxO factors are necessary to prevent 
overproliferation, abnormal differentiation, and long-
term depletion of NSCs [13,14]. Thus, another way 
miR-25 might increase NSPC proliferation is by de-
repressing insulin/IGF signaling. Given that PTEN can 
be a major inhibitor of insulin/IGF signaling [99,100] 
and is a known target of miR-25 in prostate cancer cells 
[101], miR-25 may target PTEN to increase insulin/IGF 
signaling and repress FoxO activity. We cannot exclude 
the possibility, however, that miR-25 negatively 
regulates insulin/IGF signaling under some circum-
stances, such as by repressing Akt or PI3K.  
 
There may even be crosstalk between the different 
pathways targeted by miR-25. In nematodes the TGFβ 
pathway has been shown to genetically interact with the 
insulin/IGF-FoxO pathway to regulate lifespan [84]. In 
mammals TGFβ promotes hematopoietic stem cell 
quiescence by downregulating Akt activity and 
upregulating FoxO3 activity [85], and in glioblastoma 
cells TGFβ signaling induces Smad-FoxO transcript-
tional activation complexes that suppress proliferation 
[86]. In human keratinocytes, FoxO factors are required 
for the induction of a number of genes by TGFβ, 
particularly cytostatic and stress response genes [102].  
Thus, it is possible that miR-25 regulate NSPCs by 
coordinately modulating insulin/IGF and TGFβ 
networks. 
 
Regulation of miR-106b~25 by FoxO proteins  
 
Our experiments suggest that FoxO3 regulates miR-
106b~25 in a complex manner. FoxO3 binds to a site in 
the first intron of miR-106b~25/Mcm7 in NSPCs. In 
FoxO3-null NSPCs, while Mcm7 mRNA abundance 
was decreased, the levels of mature miR-106b~25 
members were not decreased, and were even slightly 
increased. Thus, FoxO3 might transcriptionally activate 
miR-106b~25/Mcm7, but act to repress miR-106b, 
miR-93, and miR-25 at a different promoter or at 
posttranscriptional steps like precursor cleavage, 
nuclear export, base editing, and degradation.  
 
Other factors complicate our ability to define the 
regulation of miR-106b~25 by FoxO3. It is possible that 
in self-renewal culture conditions FoxO3 is bound near 
the promoter of miR-106b~25 but exerts control over 
miR-106b~25 expression only in other conditions such 
as differentiation, low nutrient levels, oxidative stress, 
or low oxygen tension. As NSPC cultures are 
heterogeneous, containing mixtures of stem cells, 
progenitor cells, and even some differentiated progeny 
[103,104], FoxO3 might also alter miR-106b~25 
expression differently in different cell types. Such 
differential regulation would be consistent with FoxO3 
and miR-106b~25 both promoting neuronal 
differentiation but having opposite effects on NSPC 
proliferation [13,14]. In these scenarios, FoxO3 would 
serve as one component of a “coincidence detector” 
regulating miR-106b~25, which in turn might indirectly 




This study shows that miR-106b~25 members modulate 
NSPC proliferation and differentiation and could 
potentially be regulated by the pro-longevity 
transcription factor FoxO3 under some circumstances. 
These results suggest a role for miR-106b~25 in normal 
adult stem cell function, in addition to a known role in 
cancer cells. Understanding how miR-106b~25 and 
FoxO3 function in NSPCs could reveal new strategies 
for preventing the loss of neurogenesis in adults, 




Constructs.  For miRNA overexpression, the 725-bp 
segment of the mouse Mcm7 gene containing the miR-
106b, miR-93, and miR-25 precursors was cloned 
between the XhoI and PmeI sites of the MDH1-PGK-
GFP 2.0 vector [105] using the primers F: 5’-
AAACTCGAGCCTGCTGGCCATTCTCCGACTTTC 
C-3’ and R: 5’-
AAAGTTTAAACGGATCTTTCTTTGCTCCAGCTT
CAAGC-3’. The 350-bp segment of the mouse Mcm7 
gene containing the miR-25 precursor only was cloned 
between the XhoI and EcoRI sites of the MDH1-PGK-
GFP 2.0 vector using the primers F: 5’-
   




For luciferase assays, the 500-bp region of the mouse 
Mcm7 intron containing the FoxO3 binding site was 
cloned between the KpnI and XhoI sites of the pGL3-
SV40 vector (Promega) using the primers F: 5’-
AAAGGTACCGCAGTGTTCCTTTTCACAAGTCCG
-3’ and R: 5’-
AAACTCGAGCGTGTGTAAACAGTGTCCTTCCGC
-3’. Mutations in the FoxO binding sequence were made 
using the primers F: 5’-
CCGCTCTTAATAGACAAAGAAGCACATGGGCC
CAGATTCC-3’ and R: 5’-
GGAATCTGGGCCCATGTGCTTCTTTGTCTATTA
AGAGCGG-3’, and this mutated enhancer was 
subcloned into a new pGL3-SV40 backbone. The 
positive control plasmid, pGL3-SV40 containing three 
repeats of the FoxO3 binding site in the FasL promoter, 
and the FoxO3 expression plasmids were described 
previously [55]. 
 
Antibodies.  For immunocytochemistry, the primary 
antibodies used were rat anti-BrdU (AbD Serotec; 
1:500), goat anti-GFP (Rockland; 1:500), rabbit anti-
Tuj1 (Covance; 1:1000), rat anti-GFAP (Calbiochem; 
1:1000), and mouse anti-O4 (a gift from Ben Barres; 
1:1000). Fluorescent secondary antibodies were from 
Jackson Immuno-Research and Molecular Probes 
(Invitrogen) and were used at 1:400 dilutions. The 
antibodies for ChIP were rabbit anti-FoxO3 “NFL” 
(Brunet laboratory) and rabbit IgG (Zymed). 
 
NSPC isolation and culture.  Each NSPC culture was 
generated from four to eight FVB/N mice (1:1 male-
female ratio). Whole brain was extracted from each 
animal, and the olfactory bulbs, cerebellum, and 
brainstem were discarded. To dissociate the forebrain 
tissue, brains were diced, treated at 37°C for 30 min 
with HBSS (Invitrogen) containing 2.5 U/ml Papain 
(Worthington), 1 U/ml Dispase II (Roche), 250 U/ml 
DNase I (Sigma), and 1X penicillin-streptomycin-L-
glutamine (PSQ; Invitrogen), and then mechanically 
dissociated in DMEM/F12 (Invitrogen) containing 10% 
fetal bovine serum (FBS; Invitrogen) and 1X PSQ. 
NSPCs were purified from myelin with a 22.5% Percoll 
gradient (GE Healthcare) and then from red blood cells 
with a 58.5% Percoll gradient. Freshly isolated NSPCs 
were considered “passage 1.” 
 
NSPCs were grown at 5% CO2 in a 37°C incubator at 
50,000 cells/ml in Neurobasal A Medium (NBA; 
Invitrogen) supplemented with 1X PSQ, 1X B-27 
Supplement Minus Vitamin A (B27; Invitrogen), 20 
ng/ml recombinant human bFGF (PeproTech), and 20 
ng/ml recombinant human EGF (PeproTech). Cells 
were fed every 2 days by replacing half the media and 
replenishing bFGF and EGF; cells were transferred to a 
new plate every 4 days. NSPCs grew to full neurosphere 
colonies every 5-8 days, and were passaged using 
Accutase (Millipore) for dissociation. 
 
miRNA overexpression by retroviral infection. HEK 
293T cells were co-transfected with the expression 
vector MDH1-PGK-GFP 2.0 containing either miR-
106b~25 or no insert (empty control) and the pCL-Eco 
viral packaging vector in a 2:1 ratio, using the calcium 
phosphate transfection method. The media was changed 
to NBA containing 1X PSQ and 1X B27 6-8 h later. 
The next day, NSPCs were dissociated and plated at 
50,000 cells/ml on plates coated with 50 µg/ml poly-D-
lysine (Sigma). The following day, NSPCs were 
infected by replacing half the media with 0.45 µm-
filtered virus-containing supernatant from the 293T 
cultures and replenishing the growth factors. Sixteen 
hours later, the infection was stopped by replacing all 
the media with NSPC-conditioned media and fresh 
media in a 1:1 ratio and replenishing growth factors. 
NSPCs were fed every other day until they were 80% 
confluent, and then detached with Accutase and grown 
in suspension. After NSPCs had grown to full 
neurospheres, RNA and protein were collected, and 
cells were plated for proliferation assays. 
 
miRNA knockdown.  NSPCs were plated at 100,000 
cells/ml in 0.5 ml NBA containing 1X L-glutamine 
(Invitrogen) and 1X B27 with growth factors in a poly-
D-lysine-coated well of a 24-well plate. The next day, 
45 nM locked nucleic acid (LNA) oligonucleotide 
(Exiqon) was diluted with 100 µl Opti-MEM 
(Invitrogen), incubated with 1 µl Lipofectamine PLUS 
reagent (Invitrogen) per 1 µg nucleic acid for 5 min, and 
then incubated with 6 µl Lipofectamine LTX reagent 
(Invitrogen) per 1 µg nucleic acid for 30 min before 
being added to cells. The media was changed to 1 ml 
NBA containing 1X PSQ and 1X B27 with growth 
factors 4-6 h later.  
 
Proliferation assays. One week after retroviral infection 
(when NSPCs had grown to full neurospheres), NSPCs 
were dissociated and plated on nitric acid-treated glass 
coverslips (Bellco) coated with poly-D-lysine. Two 
days later, BrdU (EMD Biosciences) was added to a 
final concentration of 10 µM, or EdU (Invitrogen) was 
added to a 5 µM final concentration. One hour later, 
NSPCs were fixed in 4% paraformaldehyde in PBS for 
12 min. The coverslips were blocked for 1 h with 10% 
donkey serum and 0.1% Triton in PBS and then 
incubated with goat anti-GFP antibody for 2 h. The 
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for 10 min and incubated with 0.4% Triton for 30 min. 
DNA was denatured with 2 N HCl for 10 min. After 1 h 
of blocking, coverslips were incubated with rat anti-
BrdU antibody for 2 h. The coverslips were incubated 
with Texas Red donkey anti-rat and FITC donkey anti-
goat secondary antibodies for 1 h. The coverslips were 
mounted on slides using Vectashield with DAPI (Vector 
Labs). 
 
Two days after transfection with LNA probes, EdU was 
added to a final concentration of 5 µM. One hour later, 
NSPCs were fixed in 4% paraformaldehyde and 2% 
sucrose for 12 min. Cells were permeabilized with 0.4% 
Triton in PBS for 30 min and blocked with two 3% 
BSA (USB) rinses. Cells were then incubated in 1X 
Click-iT Reaction Buffer, 4 mM CuSO4, 1:400 Alexa 
Fluor 594 azide, and 200 nM Click-iT EdU Buffer 
Additive (Invitrogen) for 30 min. Cells were then 
washed with 3% BSA, rinsed with PBS, and mounted 
on slides using Vectashield with DAPI. 
 
Coverslips were examined using a Zeiss Axioskop 2 
Plus microscope and digital camera with AxioVision 4 
software. For quantification, 3-6 random fields (about 
1000-2000 cells) were counted in a blinded manner, 
using Metamorph 7.0 software. 
 
Differentiation assays.  NSPCs were dissociated and 
plated on nitric acid-treated coverslips coated with poly-
D-lysine at a density of 25,000 cells/ml. NSPCs were 
infected the next day, and the infection was stopped 
after 16 h. Two days later, NSPCs were differentiated 
by changing the media to NBA containing 1X PSQ, 1X 
B27, and 1% FBS. The media was replaced every other 
day. After 7 days of these differentiation conditions, 
NSPCs were stained for GFAP, Tuj1, or O4. For GFAP 
and Tuj1 staining, NSPCs were fixed in 4% 
paraformaldehyde and 2% sucrose. The coverslips were 
blocked for 1 h with 10% donkey serum and 0.1% 
Triton in PBS, and then incubated with rabbit anti-Tuj1 
antibody for 2 h. After rinsing with PBS containing 
0.01% Tween and blocking for another 15 min, 
coverslips were incubated with Texas Red donkey anti-
rabbit or anti-rat secondary antibody for 1 h. For O4 
staining, NSPCs were blocked with 5% goat serum and 
7.5% BSA in PBS for 1 h and then incubated with 
mouse anti-O4 antibody (in 10% goat serum, 1% BSA, 
and 100 mM L-lysine in PBS) for 2 h. After rinsing 
with PBS, cells were fixed in 4% paraformaldehyde and 
2% sucrose, blocked for another 15 min, and then 
incubated with Alexa Fluor 546 goat anti-mouse 
secondary antibody for 1 h. Coverslips were mounted 
on slides using Vectashield with DAPI. The total 
number of neurons on each coverslip was counted in a 
blinded manner, and the total number of nuclei was 
estimated by counting 5 random fields (about 300-600 
cells) in a blinded manner. 
 
Target prediction.  TargetScan (www.targetscan.org, 
version 5.1) was used to predict all conserved targets for 
mouse miR-25. This target list was analyzed using 
PANTHER (www.pantherdb.org, version 7) to compare 
Biological Process associations for genes in this list and 
the reference list, “NCBI: M. musculus genes,” or 
analyzed with GSEA Molecular Signatures Database 
(www.broadinstitute.org/gsea/msigdb/, version 3.0) to 
compute overlaps for genes in this list and “CP” 
(Canonical Pathways) and “C5” (GO Gene Sets).             
The DIANA-miRPath program 
(http://diana.cslab.ece.ntua.gr/pathways/) using 
DIANA-microT-3.0-Strict was used to predict and 
analyze conserved targets for mouse miR-25 in the 
KEGG database. 
 
RT-qPCR. Total RNA was extracted from NSPCs using 
the miRVana kit (Ambion). RNA was treated to remove 
genomic DNA in a reaction containing 100 ng/μl RNA, 
1 U/μl RNase OUT (Invitrogen), and 10 U/μl DNase I 
(Invitrogen) at 37°C for 15 min and 75°C for 15 min.  
 
miRNA expression was quantified using the miRCURY 
LNA miRNA PCR system or the miRCURY LNA 
Universal RT miRNA PCR system, according to the 
manufacturer’s instructions (Exiqon). Samples were run 
in triplicate on a C1000 Thermal Cycler with the 
CFX96 Real-Time software (Bio-Rad), and miRNA 
expression was normalized to 5S RNA expression. 
 
To quantify Mcm7 mRNA expression, RT was carried 
out using the High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems). Each reaction 
contained 1X RT Buffer, 4 mM each dNTP, 1X 
Random Hexamers, 1 U/µl RNase OUT, 2.5 U/µl 
MultiScribe Reverse Transcriptase, and 45-90 ng/µl 
RNA. RT was performed at 25°C for 10 min, 37°C for 2 
h, and 85°C for 5 min. Each 20-µl qPCR reaction 
contained 0.25 µM forward (F) Primer, 0.25 µM reverse 
(R) Primer, 10 µl iQ SYBR Green Supermix (Bio-Rad), 
and 0.625 µl RT reaction. The program used was 95°C 
for 10 min; 40 cycles of 95°C for 20 sec, 55°C for 20 
sec, and 72°C for 45 sec. Samples were run in triplicate, 
and Mcm7 expression was normalized to β-actin 
expression. The Mcm7 primers were F: 5’-
TGAACACCGGCTGATGATGG-3’ and R: 5’-
GGCCTCGGAAATACAACTCAA-3’. The β-actin 
primers were F: 5’-TGTTACCAACTGGGACGACA-
3’ and R: 5’-CTCTCAGCTGTGGTGGTGAA-3’.  
 
Chromatin immunoprecipitation.  ChIP  was  performed 
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Immunoprecipitated chromatin was analyzed with 
qPCR: each 20-µl reaction contained 2.5 µl DNA, 10 µl 
iQ SYBR Green Supermix, 0.25 µM F primer, and 0.25 
µM R primer. Triplicate reactions were run with the 
following program: 94°C for 3 min; 40 cycles of 95°C 
for 20 sec, 57°C for 30 sec, and 72°C for 30 sec. The 
primers to amplify the region surrounding the FHRE 
FoxO3 binding site in the Mcm7 first intron were F: 5’-
TAGGCCTCCTCTGCACTCAT-3’ and R: 5’-
AGGAATCCTGGGCTGTGAG-3’. The negative 
control primers to amplify an intergenic region lacking 
a Forkhead binding sequence were F: 5’-
GGGGGATAATGATTGCAAAA-3’ and R: 5’-
GCGTGGACAGAGATCTAGGC-3’. For each 
chromatin sample, a standard curve using five 5-fold 
dilutions of input chromatin was used to quantify 
binding at each target site in the ChIPs: linear 
regression (y=-ax+b) was performed on Ct versus 
log5(input), and the amount of a site in the FoxO3 ChIP 




Electrophoretic mobility shift assay.  Complementary 
oligonucleotides (20 µM) were annealed in 100 mM 
NaCl by heating at 80°C for 5 min and then cooling 
slowly to room temperature. Annealed probe (1 µM) 
was labeled with 20 µCi/µl 
32P-γ ATP and 1 U/µl T4 
PNK at 37°C for 1 h. Annealed probes were purified on 
15% polyacrylamide and resuspended in 1X TE pH 8.  
 
Each binding reaction was performed in Binding Buffer 
(200 mM Tris-HCl pH 7.5, 200 mM KCl, 200 mM 
MgCl2, 2% NP-40, 10% glycerol, 5 mM DTT, and 500 
ng/μl salmon sperm DNA) and contained 50 ng/µl GST 
or human FoxO3-GST, 1000 cpm/μl hot probe (5 nM 
FHRE probe; 3 nM positive control probe), and 0, 5, 50, 
or 500X competing cold probe. The reactions were 
incubated at room temperature for 20 min and then 
resolved on 4% non-denaturing PAGE at 4°C. The gels 
were dried and then autoradiographed for 4 days. The 
positive control oligonucleotides for a site bound by 
FoxO3 near its own promoter [106] were F: 5’-
AAATAACACACACGTGTGCTGGTAAACAAGCG
CGCCAGCC-3’ and R: 5’-
GGCTGGCGCGCTTGTTTACCAGCACACGTGTGT
GTTATTT-3’. The oligonucleotides for the FHRE site 
within the Mcm7 intron region bound by FoxO3 in 
ChIP experiments were F: 5’-
GGCCCATGTGCTTCTTTGTTTACTAAGAGCGGA
AGCAG-3’ and R: 5’-
CTGCTTCCGCTCTTAGTAAACAAAGAAGCACAT
GGGCC-3’. The oligonucleotides for this FHRE site 
containing mutations in the FoxO consensus binding 
sequence were F: 5’-
GGCCCATGTGCTTCTGTGTCTATTAAGAGCGGA




Luciferase assays. HEK 293T cells were plated in 24-
well plates at 150,000 cells/ml. The next day, they were 
transfected using the calcium phosphate method with 
400 ng each of FoxO3 expression plasmid, pGL3-SV40 
firefly luciferase plasmid, and pRL-null Renilla 
luciferase plasmid. Two days after transfection, cells 
were lysed with 0.5 ml Passive Lysis Buffer (Promega) 
and luciferase activity was measured with the Dual 
Luciferase Reporter Assay system. Triplicate 
transfections were averaged within each experiment, 
and firefly luciferase activity was normalized to Renilla 
luciferase activity. 
 
Statistical analysis.  Gene expression (RT-qPCR 
experiments) was analyzed using one-sample two-tailed 
t-tests. NSPC phenotype (proliferation and 
differentiation assays) was analyzed using paired two-
tailed t-tests. The luciferase assay experiments were 
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